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Abstract
 
We found previously that Id3, which inhibits transcriptional activities of many basic helix-
loop-helix transcription factors, blocked T and B cell development but stimulated natural killer
(NK) cell development. Here we report that ectopic expression of Id3 and another Id protein,
Id2, strongly inhibited the development of primitive CD34
 
1
 
CD38
 
2
 
 progenitor cells into
CD123
 
high
 
 dendritic cell (DC)2 precursors. In contrast, development of CD34
 
1
 
CD38
 
2
 
 cells
into CD4
 
1
 
CD14
 
1
 
 DC1 precursors and mature DC1 was not affected by ectopic Id2 or Id3 ex-
pression. These observations support the notion of a common origin of DC2 precursors, T and
B cells. As Id proteins did not block development of NK cells, a model presents itself in which
these proteins drive common lymphoid precursors to develop into NK cells by inhibiting their
options to develop into T cells, B cells, and pre-DC2.
Key words: dendritic cells • dendritic cell precursors • basic helix-loop-helix transcription 
factors • idiotype proteins • lymphoid development
 
Introduction
 
It is commonly accepted that mature lymphoid cells are de-
rived from a common lymphoid precursor (CLP).
 
1
 
 Both in
humans (1) and mice (2), the CLP has been described in
terms of expression of cell surface proteins. Recent work
has provided some insight into the mechanisms of cell fate
specification of these CLPs, as several transcription factors
have been identified that control differentiation of particu-
lar lymphoid lineages. Among these are E proteins, which
belong to the family of basic helix-loop-helix (bHLH)
transcription factors. Members of this family have been
shown to play a role in lineage decisions in many develop-
mental systems in organisms varying from yeast to mammals
(3, 4). bHLH proteins are characterized by two conserved
domains: an HLH domain that mediates protein–protein
interactions and a basic domain that confers binding of
bHLH dimers to sequences present in target genes. The E
proteins control development in concert with the structur-
ally related inhibitor of DNA binding (Id) proteins (5). The
four Id proteins, which have different tissue distributions,
possess a HLH domain and can interact effectively with
bHLH factors, preferentially with E proteins. However, as
Id proteins lack a basic motif, complexes of Id and bHLH
factors fail to bind to DNA and are therefore transcriptional
inactive.
The combined dosage of bHLH and Id proteins is the
determining factor in certain cell lineage decisions. The E
proteins, E12 and E47, which are different splice products
of a single gene, E2A, are essential for B cell development
(6, 7). They control either directly or indirectly the expres-
sion of PAX-5 (6), which shuts off the developmental op-
tions of lymphoid precursors except to the B cell lineage,
thereby consolidating further B cell development (8, 9).
E2A proteins are also involved in T cell development (10).
The thymus of E2A
 
2
 
/
 
2
 
 mice is much smaller than that of
wild-type mice, and T cell development is partially blocked
at the transition of uncommitted into committed T cell
precursors (10). Mice deficient for the E protein HEB also
have a small thymus and a relative block early in T cell de-
velopment (11). Bone marrow cells of mice deficient for
the bHLH factor HES-1, which belongs to a different class
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a
 
, pre-TCR-
 
a
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of HLH factors (4), are unable to develop into T cells upon
transfer into recombination activating gene (RAG)-1
 
2
 
/
 
2
 
mice (12). Together, these findings indicate that multiple
bHLH transcription factors are involved in T cell develop-
ment. Concordant with findings in the mouse, we docu-
mented that ectopic expression of one of the Id proteins,
Id3, in human lymphoid precursors blocks T and B cell de-
velopment. In contrast, NK cell development was pro-
moted by Id3 (13–15). Recently, it was reported that mice
deficient for another member of the Id family, Id2, lack
NK cells (16). Together, these findings would be compati-
ble with the idea that Id proteins consolidate NK develop-
ment by shutting off alternative developmental options of
lymphoid precursor cells.
To obtain further support for the hypothesis that E and
Id proteins control lymphopoiesis, we sought to test the ef-
fect of ectopic expression of Id2 and Id3 on development
of another lymphoid cell, the lymphoid dendritic cell
(DC). A considerable body of evidence supports the notion
that DCs can originate either from myeloid or lymphoid
precursors. Cell transfer studies suggest that murine thymic
DCs, which express CD8
 
a
 
, are related to lymphoid cells, as
CD8
 
a
 
1
 
 DCs can be generated from thymic precursors that
are almost entirely devoid of myeloid potential (17, 18).
Recently, we characterized a cell type present in the
medulla of the human thymus with the phenotype
CD3
 
2
 
CD4
 
1
 
CD45RA
 
1 
 
expressing high levels of IL-3R
 
a
 
(CD123). These cells rapidly differentiate into DCs in vitro
upon incubation with IL-3 or IL-3 and CD40 ligand
(CD40L [19]). Interestingly, the thymic CD123
 
high
 
 DC
precursors are very similar to the recently described pre-
DC2 (pDC2) present in the T cell areas of human tonsils
(20) and in peripheral blood of adults and neonates (21,
22). The CD123
 
high
 
 pDC2 are also capable of secreting
high levels of IFN-
 
a
 
 and -
 
b
 
 after infection with HSV-1 or
influenza virus (23, 24). Therefore, they appear to be iden-
tical to a cell type described previously as the natural IFN-
producing cell (NIPC [25, 26]). A couple of characteristics
of the thymic CD123
 
high
 
 pDC2 make it highly likely that
they are of lymphoid origin. They express the lymphoid
cell–associated markers CD2, CD5, and CD7, which are
preferentially expressed on lymphocytes, and lack the my-
eloid cell–associated markers CD11c, CD13, and CD33
(19). Importantly, the thymic DC precursors as well as the
tonsillar pDC2 expressed high levels of pre-TCR-
 
a
 
 (pT
 
a
 
)
transcripts (19), strongly suggesting a close developmental
relationship of these pDC2 with T cells.
In this study, we describe a novel assay for development
of CD123
 
high
 
 pDC2. Using this assay we demonstrate that
ectopic expression of Id2 or Id3 into CD34
 
1
 
CD38
 
2 
 
fetal
liver precursors inhibited generation of CD123
 
high
 
 pDC2
but did not affect development of CD34
 
1
 
 cells into DCs
with GM-CSF and TNF-
 
a
 
. Id3 also inhibited the genera-
tion of CD123
 
high
 
 pDC2 from thymic CD34
 
1
 
 cells. As Id
overexpression inhibits T cell, B cell, and CD123
 
high
 
 pDC2
development but not NK development, our data suggest
that Id proteins allow NK development by inhibiting alter-
native developmental options of lymphoid precursors.
 
Materials and Methods
 
Construction of the Vectors and Transduction of Target Cells.
 
Preparation of the internal ribosomal entry site (IRES)-green flu-
orescent protein (GFP) and Id3-IRES-GFP constructs have been
described previously (14). As a control we constructed into the
LZRS-linker-IRES-GFP vector a form of murine Id3 with a
mutation in the HLH domain (R72P; provided by Dr. G. Kato,
Johns Hopkins University, Baltimore, MD) that has lost the ca-
pacity to dimerize with bHLH factors (27). The HLH domains of
human and murine Id3 are identical. The coding sequence of hu-
man Id2 was cut from the pSG5 Id2 vector (a gift of Dr. R. de
Groot, University of Utrecht, Utrecht, Netherlands) with Not1
and was ligated in the Not1 site of polylinker from our plasmid
LZRS-linker-IRES-GFP. Selected clones were checked for the
correct orientation of the Id2 coding sequence by sequencing.
Helper-free recombinant retroviruses were produced after trans-
fection into a 293T-based amphotropic retroviral packaging cell
line, Phoenix (28).
 
Retroviral Transduction.
 
The transduction procedure using re-
combinant human fibronectin fragments was performed by a
method described previously (13, 14). The sorted CD34
 
1
 
CD38
 
2
 
fetal liver or the CD34
 
1
 
CD1a
 
2
 
 thymocytes were cultured over-
night in the presence of 10 ng/ml human IL-7 and 20 ng/ml
stem cell factor (SCF; both from R&D Systems). After overnight
culture, the cells were transduced by incubating them for 6 h
with virus supernatant in non-tissue culture–treated Falcon petri
dishes (3-cm diameter; Becton Dickinson) coated with 30 mg/ml
recombinant human fibronectin fragment CH-296 (RetroNec-
tin™; Takara Shuzo Co. [29]). After transduction, the cells were
washed twice in medium. The transduction efficiency was tested
by determining the percentage of GFP
 
1
 
 cells 2 d after transduc-
tion.
 
Antibodies.
 
FITC-labeled antibodies specific for CD3, CD5,
CD7, CD8, CD14, CD19, CD33, CD40, CD45RA, and CD56,
PE-labeled antibodies against CD2, CD4, CD13, CD80, CD123,
and HLA-DR, and an unlabeled, nonblocking, anti-CD123 anti-
body were purchased from Becton Dickinson. Anti-CD1a–PE,
anti-CD54–PE, anti-CD83–PE, and anti–TCR-
 
g
 
/
 
d
 
–PE were
obtained from Beckman Coulter/Immunotech, and anti-
CD11c–PE was purchased from Biosource International. Anti-
CD4–Tricolor was obtained from Dako and anti–TCR-
 
a
 
/
 
b
 
–
Tricolor from Beckman Coulter/Immunotech.
 
Isolation of CD34
 
1
 
 Cells from Fetal Liver and Postnatal Thy-
mus.
 
Fetal liver was obtained from elective therapeutic abor-
tions. Gestational age was determined by crown-rump length and
ranged from 14 to 17 wk. The use of this tissue was approved by
the medical ethical committee of the Netherlands Cancer Insti-
tute and was contingent on informed consent. Human fetal liver
cells were isolated by gentle disruption of the tissue by mechani-
cal means, followed by density gradient centrifugation over Fi-
coll-Hypaque (Lymphoprep; Nycomed Pharma). The CD34
 
1
 
cells were isolated from these samples by immunomagnetic cell
sorting, using a CD34 separation kit (varioMACS; Miltenyi Bio-
tec) and were further purified by sorting with a FACStar
 
PLUS™
 
(Becton Dickinson). Postnatal thymus samples were from chil-
dren undergoing open-heart surgery. CD34
 
1
 
 cells, enriched by
immunomagnetic cell sorting, were labeled with anti-CD34–
FITC (HPCA-2; Becton Dickinson) and anti-CD1a–PE (Beck-
man Coulter/Immunotech) antibodies, and the CD34
 
1
 
CD1a
 
2
 
cells were purified by FACS
 
®
 
 sorting. The purity of the popula-
tions used in this study was 
 
.
 
99%.
 
Monolayer Cell Culture.
 
The monolayer cell culture assays for
differentiation of CD123
 
high
 
 pDC2 were carried out with the 
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murine bone marrow stromal cell line S17 (a gift from Dr. Ken
Dorshkind, UCLA, Los Angeles, CA). 2 d before their use in
coculture experiments, S17 cells were plated in 24-well tissue
culture plates (15 
 
3
 
 10
 
4
 
 cells/well in 1 ml medium) or in 96-well
flat-bottomed plates (3–5 
 
3
 
 10
 
3 
 
cells/well in 100 
 
m
 
l medium).
Monolayer cultures were initiated by seeding 5–10 
 
3
 
 10
 
4
 
 pro-
genitor cells/ml to the wells seeded with S17 cells. After incuba-
tion in Yssel’s medium (30) supplemented with 5% FCS (Bio-
Whittaker), the cells were harvested, stained with FITC-, PE-, or
Tricolor-labeled human specific antibodies, and analyzed by flow
cytometry for cell surface phenotype.
 
Generation of DCs in IL-3- and CD40L-supported Cultures of
Thymic DC Precursors.
 
CD123
 
high
 
 cells were sorted from cocul-
tures of CD34
 
1
 
 cells with S17 cells. The sorted cells were cul-
tured in a 96-well flat-bottomed plate in the presence of 10 ng/
ml IL-3 with or without 10
 
4 
 
CD40L-transfected mouse fibro-
blasts (provided by Dr. J. Banchereau, Schering-Plough Corpora-
tion, Dardilly, France). The L cells were cultured as a monolayer
and had been irradiated with 10
 
4 
 
rads before use in the DC differ-
entiation assay. Culture medium consisted of Yssel’s medium
with 5% normal human serum.
 
IFN-
 
a
 
 Production by CD123
 
high
 
 pDC2.
 
CD123
 
high
 
CD45RA
 
1
 
cells were purified by FACS
 
®
 
 sorting and resuspended at a con-
centration of 10
 
6
 
 cells/ml in Yssel’s medium supplemented with
2% human serum. 200 
 
m
 
l of this cell suspension were mixed with
10 PFU/well HSV-1 of a 96-well round-bottomed plate (Costar)
and incubated for 24 h at 37
 
8
 
C in a 5% CO
 
2
 
 atmosphere. The
IFN-
 
a
 
 levels were measured with an ELISA (Biosource Interna-
tional) according to the instructions of the manufacturer.
 
Generation of DCs from CD34
 
1
 
 Precursor Cells in Media Contain-
ing GM-CSF and TNF-
 
a
 
.
 
Development of CD34
 
1
 
 fetal liver
cells and thymocytes to DCs was studied in an in vitro
 
 
 
culture
system described previously (31). 10,000 progenitor cells were
cultured in 200 
 
m
 
l Yssel’s medium in the presence 10 ng/ml SCF
(R&D Systems), 50 ng/ml GM-CSF (a gift of Dr. R. Kastelein,
DNAX, Palo Alto, CA), and 50 U/ml TNF-
 
a
 
 (R&D Systems)
per well in 96-well microtiter plates (Costar). Appearance of DCs
was monitored by analyzing the phenotype by flow cytometry.
 
Reverse Transcription PCR Assays and Sequencing of the PCR
Product.
 
RNA was isolated from FACS
 
®
 
-sorted CD123
 
high
 
 cells
using TRIzol reagent (GIBCO BRL) according to the manufac-
turer’s instructions and reverse transcribed using a poly-dT
 
 
 
oligo-
nucleotide (Promega) and 400 U Moloney MuLV reverse tran-
scriptase (GIBCO BRL) at 42
 
8
 
C for 1 h. PCR assays were
carried out in 50 
 
m
 
l reaction volumes using 1 
 
m
 
l cDNA template,
2 mM MgCl
 
2
 
, 0.25 mM of each dNTP, 1 
 
m
 
M of each primer,
and 3 U Taq polymerase (GIBCO BRL) in 1
 
3
 
 buffer (10 mM
Tris-HCl, pH 8.5, 50 mM KCl). Reaction conditions were as
follows: a 5-min denaturation step at 94
 
8
 
C was followed by 30
cycles of 1 min at 94
 
8
 
C, 1 min at 65
 
8
 
C, and 2 min at 72
 
8
 
C. The
PCR products were separated on 1.2% agarose gels, stained with
ethidium bromide, and analyzed by videodensitrometry using the
Eagle Eye still video system and Eagle Sight Software (Strat-
agene).
The hypoxanthine ribosyltransferase (HPRT) and pT
 
a
 
 prim-
ers that were used were: HPRT sense, 5
 
9
 
-TATGGACAG-
GACTGAACGTCTTGC-3
 
9
 
; HPRT antisense, 5
 
9
 
-GACACA-
AACATGATTCAAATCCCTGA-3
 
9
 
; pT
 
a
 
 sense, 5
 
9
 
-GTCCA-
GCCCTACCCACAGGTGT-3
 
9
 
; pT
 
a
 
 antisense, 5
 
9
 
-CGGGAA-
TTCGACGTCCCTGGCTGTAGAAGCCTCTC-3
 
9
 
. These
primers amplify an oligonucleotide spanning position 122 to 420
of the pT
 
a
 
 sequence (sequence data are available from EMBL/
GenBank/DDBJ under accession no. U36759; the ATG is at po-
 
sition 82). To confirm the identity of the pT
 
a
 
 PCR product, the
PCR fragments were isolated from the 1.5% agarose 1
 
3
 
 Tris-
HCl/acetate/EDTA (TAE) gel and subjected to DNA sequenc-
ing analysis using either primer used for PCR reaction. As a posi-
tive control, a retroviral vector containing the full-length pT
 
a
 
cDNA sequence was used. Sequence reactions were performed
with Big Dye Terminator chemistry according to the manufac-
turer’s protocol and analyzed on an ABI model 3700 sequencer
(Applied Biosystems).
Results
CD341 Cells Develop into CD123high pDC2 upon Cocul-
ture with the Murine Stromal Cell Line S17. The murine
stromal cell line S17 has been shown previously to induce
development of CD191 B cells from neonatal cord blood
and fetal liver CD341 cells (32, 33). In this study we ob-
served that coculture of CD341CD382 fetal liver cells with
S17 cells resulted in the appearance of IL-3Ra (CD123)high
cells that coexpressed CD45RA within 4–5 d. The propor-
tion of these cells gradually decreases upon further cul-
ture (results not shown). The percentage of CD123high
CD45RA1 cells recovered from cultures of CD341CD382
fetal liver cells with S17 cells were variable; these could be
as low as 1% and as high as 15% depending on the donor.
On the average, CD341CD382 cells expand twofold in the
4–5-d S17 cultures. Thus, starting with 105 CD341CD382
cells, between 2,000 and 30,000 CD123highCD45RA1 cells
can be recovered. Fig. 1 shows a typical experiment. The
starting CD341CD382 population (99% pure upon reanal-
ysis) did not express CD45RA and only low levels of
CD123. After 4 d of coculture with S17 cells, the
CD123highCD45RA1 cells constituted 8% of the cells. To
investigate the phenotype of these cells in more detail, we
sorted the CD1231 cells to 97% purity (Fig. 1 B) and ana-
lyzed the phenotype. All sorted cells expressed CD45RA.
They coexpressed CD4, lacked CD11c, and weakly ex-
pressed the lymphoid cell–associated markers CD2, CD5,
and CD7. They were negative for CD1a, which is ex-
pressed on Langerhans type DCs, CD3, and CD8, and for
the NK marker CD56. In other experiments we found that
these cells also did not express the costimulatory molecule
CD80 and the mature DC marker CD83 (data not shown).
Expression of the myeloid marker CD13 and CD54 (intra-
cellular adhesion molecule [ICAM]-1) was weak. The phe-
notypes of the S17-generated CD123high cells, the thymic
CD123high pDC2, and peripheral pDC2 are very similar
(19, 20, 34).
We have found previously that thymic CD123high pDC2
express pTa transcripts (19). However, we could not com-
pletely rule out the possibility that a contaminating pre-T
cell population was responsible for the pTa signal. To
check whether these transcripts are also present in S17-
generated CD123high pDC2, we purified CD123high cells
from the S17 cultures and analyzed the presence of pTa
mRNA by reverse transcription (RT)-PCR. Fig. 2 shows
that the pTa PCR product had the predicted size. The
PCR products obtained from the CD123high cells and the1778 Regulation of pDC2 Development by bHLH Factors and Id Proteins
the corresponding stretch in the pTa cDNA that was se-
quenced in parallel, confirming that the PCR samples were
derived from pTa transcripts. These data demonstrate that
S17-generated pDC2 express pTa mRNA, whereas the
freshly isolated CD341 cells did not express pTa tran-
scripts.
It has been reported that pDC2 produce high levels of
IFN-a (23, 24). To determine whether the S17-generated
CD123high cells are able to secrete IFN-a, CD341CD382
fetal liver cells were sorted and cocultured with S17 cells
for 4 d. After this incubation, the CD123highCD41 cells
were sorted and stimulated with 10 PFU/cell gamma irra-
diation–inactivated HSV-1 as indicated in Materials and
Methods. We also determined IFN-a secretion by S17-
cocultured cells that expressed no or low levels of CD123.
The S17-generated CD123high pDC2 secreted IFN-a upon
stimulation with the HSV-1 virus in two separate experi-
ments (7,500 pg/ml and 13,000 pg/ml per 106 cells),
whereas the CD1232 population secreted much lower lev-
els of IFN-a (350 pg/ml and 25 pg/ml, respectively).
To determine the capacity of the S17-generated
CD123high cells to develop into mature DCs, we sorted the
CD123highCD41 cells from the S17-cocultured cells using a
nonblocking anti-CD123 antibody and stimulated these
cells with IL-3 with or without CD40L-expressing L cells.
After 4 d of incubation, the cells acquired the veiled mor-
phology typical for DCs (results not shown). As expected,
the IL-3/CD40L–stimulated cells expressed high levels of
HLA-DR, the costimulatory molecules CD80 and CD86,
and the mature DC marker CD83 (Fig. 3). The expression
of HLA-DR and CD54 increased considerably compared
with that on the in vitro–generated pDC2 (Fig. 1). The
differentiated cells only very weakly expressed the myeloid
marker CD33, which is highly expressed on DC1. The
phenotype of these DCs is similar to that obtained after dif-
ferentiation of tonsillar and thymic CD123high pDC2 (19,
20). Although not shown, these mature DC2 very effi-
ciently stimulated proliferation of allogeneic naive CD41
CD45RA1 peripheral blood T cells confirming that these
cells are antigen-presenting DCs.
CD341CD1a2 but Not CD341CD1a1 Fetal Thymic Pre-
cursors Are Able to Develop into CD123high pDC2. The
phenotypic similarity of the S17-generated CD123high cells
with freshly isolated CD123high pDC2 and the fact that
these cells differentiated into DCs upon culture with IL-3/
CD40L indicate that the S17 coculture system can be used
as an assay for CD123high pDC2 precursor activity of
CD341 cells. Studies in the mouse have demonstrated that
thymic DCs develop from thymic precursors (35). Previous
work has shown that CD341CD1a2 thymocytes contain
bipotential T/NK cell precursors (36) and are able to de-
velop into DCs upon culture in GM-CSF–containing me-
dia (31, 37). Upon upregulation of CD1a, the capacity of
CD341 thymocytes to develop into NK cells and DCs is
lost. To determine whether CD341 thymic populations
can develop into CD123high pDC2, we sorted CD341 pop-
ulations on the basis of CD1a expression and tested these
populations in the S17 system. Fig. 4 shows that although
Figure 1. CD341CD382 fetal liver cells cocultured with S17 cells de-
velop into cells that contain CD123high pDC2. Fetal liver cells were first
enriched for CD341 cells using the MACS. The resulting cell population
was sorted and was cocultured with S17 cells. After 5 d of culture the cell
surface phenotype of sorted CD123high cells was analyzed. (A) Phenotypes
of MACS enriched CD341 cells before and after the sort. (B) CD123 and
CD45RA expression of the sorted CD341 cells at the start of the cocul-
ture with S17 cells. (C) CD45RA and CD123 expression after 5 d cocul-
ture with S17 cells. (D) The phenotype of CD123high cells, sorted from
the S17 cocultures. The sorted cells were stained with Tricolor- and PE-
labeled antibodies. Tricolor-labeled CD5, CD7, and CD56 antibodies
were used, and the other antibodies were labeled with PE. The histo-
grams of the Tricolor- and PE-labeled Igs are slightly different because of
the different labels. FSC, forward side scatter.
thymocytes were recovered from the agarose gel and se-
quenced. As a positive control, we also sequenced a retro-
viral vector containing the full-length pTa cDNA. The se-
quences of the two PCR samples were identical to that of1779 Spits et al.
CD341CD1a2 cells generated CD41CD45RA1CD123high
pDC2, CD341CD1a1 cells failed to develop into
CD123high pDC2 upon coculture with S17 cells. In a paral-
lel experiment, the same sorted CD341CD1a1 cells devel-
oped into T cells in a fetal thymic organ culture system
(data not shown), as was found previously (15, 38). These
results demonstrate that upon upregulation of CD1a, the
cells lose their capacity to develop into CD123high pDC2.
Note that coculture of CD341CD1a2 cells with S17 cells
resulted in the appearance of CD123dimCD45RA1 cells,
which were not observed in the cultures with CD341
CD1a1 cells. The nature of these cells is presently under
investigation.
Ectopic Expression of Id2 or Id3 in CD341 Precursors Com-
pletely Inhibits Development of CD123high pDC2 but Not De-
velopment of Myeloid DC1. We have documented that en-
forced expression of Id3 into CD341 precursors inhibited
their capacity to develop into T and B cells without affect-
ing their NK cell or CD14 myeloid precursor activity (13–
15). These findings suggest a role for one or more Id pro-
tein(s) as switch factor(s) regulating T versus NK choices in
the thymus and B versus NK choices in the bone marrow.
Recently, it was reported that Id22/2 mice lack NK cells
(16). In contrast, Id32/2 mice have normal NK cell devel-
opment (Murre, C., personal communication). These ob-
servations strongly suggest that Id2 is the physiological
factor determining lineage choices in the lymphoid
compartment and predict that Id2 has an activity similar to
that of Id3 in blocking T cell development. Indeed, ectopic
expression of Id2 in CD341CD1a2 thymocytes that con-
tain bipotential T/NK precursors (36) completely blocked
T cell but not NK cell development in a fetal thymic organ
culture (results not shown). To reveal a possible common
developmental pathway of T cells, B cells, NK cells, and
CD123high pDC2, we tested the effect of Id2 and Id3 over-
expression on development of the latter cells. CD341
CD382 fetal liver cells were purified and incubated over-
night with SCF and IL-7 as indicated in Materials and
Methods. The cells were then transduced with IRES-GFP,
Id2-IRES-GFP, or Id3-IRES-GFP, and cocultured with
S17. Fig. 5 A shows that compared with the GFP control,
Id2 and Id3 strongly inhibited the generation of
CD123highCD45RA1 cells. Not only the percentages of
CD123highCD45RA1 cells were much lower, but also the
absolute numbers of CD123highCD45RA1 cells were re-
duced .10-fold. To ensure that the inhibiting activity of
the Id proteins is due to their capacity to sequester E pro-
teins, we tested CD341CD382 cell transduced with a mu-
tated Id3 (DId3) that is unable to dimerize with bHLH fac-
tors (27). As expected, DId3 failed to inhibit pDC2
development (Fig. 5 B). As was also observed previously
(14), generation of CD41CD141 cells in the S17 coculture
was not inhibited by Id3 (Fig. 5 B), indicating that Id pro-
teins do not inhibit generation of DC1 precursors (mono-
cytes). Id3 slightly stimulated generation of CD41CD141
Figure 2. CD123high cells generated from CD341 cells
express pTa mRNA. Purified CD341CD382 fetal liver
cells were incubated with S17 cells. 5 d later the CD123high
cells were sorted (99% pure upon reanalysis) and analyzed
for the presence of HPRT and pTa transcripts by reverse
transcription PCR. The pTa PCR products were then re-
covered and sequenced.
Figure 3. CD123high cells generated from CD341 cells develop into
mature DC2 upon incubation with CD40L and IL-3. Purified
CD341CD382 fetal liver cells were incubated with S17 cells. 5 d later the
CD123high cells were sorted (99% pure upon reanalysis) and incubated
with CD40L-expressing mouse L cells and IL-3.1780 Regulation of pDC2 Development by bHLH Factors and Id Proteins
cells compared with the GFP only and DId3 in this experi-
ment, but this effect was not observed in additional experi-
ments. Also, Id2 did not affect generation of CD41CD141
cells in the cocultures of CD341CD382 cells and S17 cells
(results not shown).
DCs can also be generated from CD34 precursor cells af-
ter culture in GM-CSF–containing media (39; for a re-
view, see reference 40). These DCs are similar to mono-
cyte-derived DCs (DC1 [21]) and most likely belong to the
myeloid lineage. Fig. 6 shows that SCF, GM-CSF, and
TNF-a–induced development of CD41, CD831, and
CD801 cells from CD341CD382 fetal liver cells was not
affected by Id2 or Id3 overexpression. Id2 and Id3 also did
not affect the percentages of cells expressing CD1a, CD13,
and CD40 (results not shown). Note that the in vitro–gen-
erated DC1 also contain cells with a high expression of
CD123. However, the great majority of these cells did not
express CD45RA. Importantly, generation of CD1231
cells in SCF, GM-CSF, and TNF-a was not inhibited by
Id2 or Id3. Thus, the lack of CD123high pDC2 cells in the
cultures of Id-transduced CD341 cells with S17 is not the
result of an inhibition of CD123 expression by Id proteins.
These data clearly indicate a different mechanism of devel-
opment of myeloid-derived DC1 and CD123high pDC2
and thus (mature) DC2. As expected, Id2 and Id3 also
inhibited the generation of CD123high pDC2 from
CD341CD1a2 thymocytes in the same way as that from
CD341CD382 fetal liver cells. However, the differentia-
tion of CD341CD1a2 thymocytes into DC1 in medium
containing SCF, GM-CSF, and TNF-a was not inhibited
at all by Id2 or Id3 (results not shown).
Discussion
In previous studies we have documented that ectopic
expression of Id3 but not of DId3 inhibited development
of primitive hematopoietic precursors into T and B cells
(13, 14). In contrast, NK cell development was stimulated
by Id3 (13). The recent observation that Id22/2 mice lack
NK cells (16), whereas NK cells are normal in Id32/2 mice
(41; Murre, C., personal communication), strongly sug-
gests that Id2 is the relevant switch factor for T/NK devel-
opment in vivo. Consistent with this notion, we found
that ectopic expression of Id2 inhibits development of T
and B cells but not NK cells (results not shown), similarly
as found previously for Id3 (13). These data strongly sug-
gest that Id2 positively regulates the development of NK
cells and at the same time shuts off the capacity of precur-
sor cells to develop into T and B cells. To test the effects of
ectopic expression of Id2 and Id3 on the development of
pDC2, we employed our observation that the murine stro-
mal cell line S17 induces development of these cells from
CD341 cells. The mechanism by which S17 stimulates
pDC2 development is unknown but it is possible that this
involves cell–cell contact and a soluble factor. Blom
et al. in this issue demonstrated that Flt-3L induces
CD341CD45RA2 cells to differentiate into pDC2 (42). As
murine Flt-3L interacts with human Flt-3 (43), this cyto-
kine may be involved in S17-mediated induction of pDC2
development. Using this assay, we demonstrate that Id2
and Id3 but not DId3 strongly blocked the development of
Figure 4. CD341CD1a2 but not CD341CD1a1 cells are able to dif-
ferentiate into CD123highCD45RA1 pDC2. CD341CD1a2 and CD1a1
thymocytes were purified and cocultured with S17 cells. After 4 d of cul-
ture, the cells were stained with CD123, CD4, and CD45RA.
Figure 5. Ectopic expression of Id2 or Id3 inhibits development of pDC2. Purified CD341CD382 fetal liver cells were transduced with IRES-GFP,
Id2-IRES-GFP, Id3-IRES-GFP (A), or Id3-IRES-GFP and DId3-IRES-GFP (B), and incubated with S17 cells for 4 d. After the culture, the cells were
stained with antibodies against the indicated antigens. (A) Staining of untransduced GFP2 and transduced GFP1 cells. (B) Staining of only the transduced
GFP1 cells.1781 Spits et al.
primitive CD341CD382 fetal liver cells and CD341
CD1a2 thymic precursors into CD123high pDC2. In con-
trast, Id3 and Id2 had no effect on S17-induced develop-
ment of CD341CD382 cells into CD41CD141 pDC1.
Moreover, neither Id2 nor Id3 inhibited SCF/GM-CSF/
TNF-a–induced DC1 development of CD341CD382
fetal liver cells and thymic CD341CD1a2 cells, respec-
tively. The differential effect of Id2 and Id3 on the devel-
opment of CD123high pDC2 compared with that on SCF/
GM-CSF/TNF-a–induced DC1 development indicates
that distinct mechanisms regulate differentiation of these
two DC lineages and strongly suggests distinct develop-
mental origins.
Cell transfer studies in the mouse support a model in
which T cells and thymic DCs are intrathymically gener-
ated from a common precursor. As the thymic precursors
are unable to develop into myeloid cells, thymic DCs are
considered to be lymphoid rather than myeloid related (18;
for a review, see reference 35). The observation that
CD123high pDC2 develop from CD341CD1a2 thymic
precursors could therefore be consistent with the notion
that these cells are of lymphoid origin. However, it should
be noted that M-CSF-R1CD341 cells have been found in
the human thymus (44). Upon culture with M-CSF and
GM-CSF, those cells can develop into DCs via a CD141
intermediate (44), indicating that the human thymus does
contain precursor cells with myeloid DC potential. The
observations that CD341CD1a2 thymocytes can develop
into DCs in SCF, GM-CSF, and TNF-a, and that this is
not blocked by Id2 or Id3 (results not shown), are consis-
tent with this notion. The presence of myeloid DC precur-
sors in the human thymus indicates that the argument that a
certain DC type is of lymphoid origin because their precur-
sors are present in the thymus is not valid, at least for the
human system. However, several characteristics of thymic
CD123high pDC2 support the notion of a lymphoid origin
of these cells. These include the presence of CD2, CD5,
and CD7, which are expressed on T and NK cells but in
general not on myeloid cells, and the lack of expression of
typical myeloid cell–associated markers CD13 and CD33
(19). Moreover, both the CD123high pDC2 generated from
CD341 cells (Fig. 2) as well as ex vivo–isolated pDC2 (19)
express pTa transcripts. The fact that these transcripts are
expressed in pre-T cells (45), uncommitted T/NK precur-
sors (46), and pDC2 (19) strongly suggests a common de-
velopmental origin of T cells and pDC2. Therefore, we
believe the hypothesis that CD123high pDC2 are of lym-
phoid origin to be a valid one. However, we realize that fi-
nal proof requires clonal analyses that demonstrate the de-
velopment of single precursors into CD123high pDC2 and
other lymphocyte lineages but not into myeloid cells. As
CD123high pDC2 cells expand very poorly in S17 cocul-
tures, culture conditions that induce extensive expansion of
CD123high pDC2 should be established before clonal analy-
ses of the DC precursor activity of putative CLP popula-
tions can be performed.
Assuming that CD123high pDC2 are of lymphoid origin,
a model presents itself in which Id proteins control lym-
phoid development by allowing NK cell development and
limiting the options of lymphoid precursors to develop into
T and B cells and CD123high pDC2. It is likely that the rel-
evant Id protein is Id2, as Id2-deficient mice (16), but not
Id3-deficient mice (Murre, C., personal communication),
lack NK cells. The phenotype of Id22/2 mice strongly sug-
gests that certain bHLH factors (the E proteins, HEB, E2A,
and E2-2 or other yet to be defined factors) inhibit the de-
velopment of NK cells. Expression of Id1, Id3 (14), and
Id2 (results not shown) is relatively high in uncommitted
CD341CD382 fetal liver cell precursors compared with
more differentiated CD341CD381 precursors. Therefore,
it is conceivable that in microenvironments, where Id2 is
not downregulated in lymphoid precursors, NK cells are
generated from these precursor cells because bHLH factors
that block NK development are sequestered. These may be
the same bHLH factors that positively control T cell, B
cell, and CD123high pDC2 development.
Figure 6. Ectopic expression
of Id2 or Id3 does not affect dif-
ferentiation of DC1. Purified
CD341CD382 fetal liver cells
were transduced with IRES-
GFP, Id2-IRES-GFP, and Id3-
IRES-GFP, and cultured with
SCF, GM-CSF, and TNF-a for
5 d. After the culture, the cells
were stained with antibodies
against the indicated antigens.1782 Regulation of pDC2 Development by bHLH Factors and Id Proteins
Id protein expression is downregulated during B cell de-
velopment (47), releasing E2A proteins that control, either
directly or indirectly, the transcription of PAX-5 (48).
PAX-5 in turn consolidates B cell development by shutting
off the options of precursor cells to develop into other lin-
eages (8). A similar mechanism may operate in the thymus
for T cells and CD123high pDC2. We have recently shown
that Id3 overexpression in early precursor cells inhibits T
cell development at the T/NK branchpoint (13) and now
show that Id2 has the same activity. Ectopic expression of
Id3 in committed T cell precursors still blocks development
of TCR-a/b1 cells (15), indicating that continued activi-
ties of bHLH factors during early stages of T cell develop-
ment are required to complete this process. Interestingly,
Id3-overexpressing pre-T cells acquire the capacity to de-
velop into cells with the phenotype and functional activi-
ties of NK cells but with TCR gene rearrangements (15).
Thus, pre-T cells may be able to develop into another cell
type when crucial bHLH factors are sequestered by overex-
pression of Id3. This situation is similar to that with PAX-5
and B cell development, as “pre-B” cells lacking PAX-5
have the capacity to develop into various other lineages, in-
cluding T and NK cells (8, 9). It is tempting to speculate
that sequestering bHLH factors inhibits the activity of a T
cell equivalent of PAX-5, releasing a block on alternative
developmental options of pre-T cells.
Several bHLH factors have now been implicated in T
cell development. These include the bHLH factors E12,
E47, HEB (10, 11), and the class VI HLH factor HES-1
(12). Elucidation of the identity of class I bHLH factors
critical for the development of CD123high pDC2 will come
from analyses for the presence of the murine equivalent of
these cells in mouse strains with E protein deficiencies.
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